Despite improvement in pathologic complete response with preoperative chemoradiation, the benefit did not extend to overall ...

Third, chemotherapy given as part of concurrent chemoradiation may act systemically and potentially eradicate distant micrometastases.

1 These data support the conclusion that patients who respond to preoperative chemoradiation therapy, who in this study were represented to a greater degree in the LAR group than in the APR group ...

Radiation and chemo are sometimes used together as chemoradiation. Targeted therapy is another treatment that searches for cancer cells in the body. It is taken by pills and can be taken at home ...

The following is a summary of “Dose-response relationships between radiation exposure, bone marrow function as measured by ...

Adding preoperative chemoradiotherapy to perioperative chemotherapy failed to boost survival, versus perioperative ...

Research presented at ESMO 2024 could have practice-changing implications for breast, gastrointestinal, genitourinary, and gynecologic cancers.

The survival rate for CAN-2409 treated PDAC patients (of 71.4%) at 24 months was much superior to the 16.7% of survival rate for the control group after chemoradiation. Besides, the CAN-2409 ...

The published belrestotug/dostarlimab data is still too immature to prove the combination’s capability to disrupt the NSCLC ...

Janssen-led randomized Phase 2 study evaluating NBTXR3 + chemoradiation followed by anti-PD-L1 for patients with inoperable, stage 3 NSCLC Study may proceed letter received from the Food and Drug ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...